Protocol
Growth Hormone
Ipamorelin Standalone Protocol [2026]
Selective GH release with minimal cortisol and prolactin elevation, suitable for extended research cycles.
Compounds
Ipamorelin
Dose: 200 mcg
Freq: Twice to three times daily
Recon: 2mg + 2mL BAC
Conc: 1,000 mcg/mL
Draw: 20 units (U-100)
Calculate Ipamorelin dose
Protocol Phases
Full Protocol
Weeks 1 to 16
Ipamorelin 200 mcg twice daily minimum. Many protocols use 200 to 300 mcg three times daily: on wake, early afternoon, and before bed. Ipamorelin tolerates longer cycles than most GHRPs due to minimal cortisol effects.
FAQ
Why choose Ipamorelin over GHRP-2 or Hexarelin?
Ipamorelin produces highly selective GH release without significant cortisol, prolactin, or ACTH elevation. This makes it suitable for longer research cycles (12 to 16 weeks) and for research subjects who want GH benefits without HPA axis disruption.
Does Ipamorelin work better alone or stacked with a GHRH?
When stacked with CJC-1295 or another GHRH analog, Ipamorelin produces significantly greater GH output. The GHRH component extends and amplifies the pulse triggered by Ipamorelin. Standalone Ipamorelin produces smaller, more frequent GH pulses and is the appropriate choice when GHRH is not being used.
How long can Ipamorelin be run continuously?
Ipamorelin is one of the few GHRPs studied over extended periods without significant receptor desensitization. Research protocols of 16 to 24 weeks are documented. Many protocols run Ipamorelin with CJC-1295 for 16 weeks, take 4 weeks off, then repeat.
Research Notes
- Ipamorelin alone without a GHRH produces roughly half the GH output of the stacked combination.
- Fast 2 hours before injection for maximum response.
- SubQ injection in abdomen is standard. Dose before bed for the strongest GH pulse overlap with sleep.
Related Protocols
For research use only. Not medical advice.